IBDEI0KP ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9314,1,3,0)
 ;;=3^Sarcoidosis of Lung
 ;;^UTILITY(U,$J,358.3,9314,1,4,0)
 ;;=4^D86.0
 ;;^UTILITY(U,$J,358.3,9314,2)
 ;;=^5002442
 ;;^UTILITY(U,$J,358.3,9315,0)
 ;;=D86.1^^39^411^47
 ;;^UTILITY(U,$J,358.3,9315,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9315,1,3,0)
 ;;=3^Sarcoidosis of Lymph nodes
 ;;^UTILITY(U,$J,358.3,9315,1,4,0)
 ;;=4^D86.1
 ;;^UTILITY(U,$J,358.3,9315,2)
 ;;=^5002443
 ;;^UTILITY(U,$J,358.3,9316,0)
 ;;=D86.2^^39^411^46
 ;;^UTILITY(U,$J,358.3,9316,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9316,1,3,0)
 ;;=3^Sarcoidosis of Lung w/ Sarcoidosis of Lymph Nodes
 ;;^UTILITY(U,$J,358.3,9316,1,4,0)
 ;;=4^D86.2
 ;;^UTILITY(U,$J,358.3,9316,2)
 ;;=^5002444
 ;;^UTILITY(U,$J,358.3,9317,0)
 ;;=D86.89^^39^411^48
 ;;^UTILITY(U,$J,358.3,9317,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9317,1,3,0)
 ;;=3^Sarcoidosis of Other Sites
 ;;^UTILITY(U,$J,358.3,9317,1,4,0)
 ;;=4^D86.89
 ;;^UTILITY(U,$J,358.3,9317,2)
 ;;=^5002453
 ;;^UTILITY(U,$J,358.3,9318,0)
 ;;=D86.9^^39^411^51
 ;;^UTILITY(U,$J,358.3,9318,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9318,1,3,0)
 ;;=3^Sarcoidosis,Unspec
 ;;^UTILITY(U,$J,358.3,9318,1,4,0)
 ;;=4^D86.9
 ;;^UTILITY(U,$J,358.3,9318,2)
 ;;=^5002454
 ;;^UTILITY(U,$J,358.3,9319,0)
 ;;=D86.86^^39^411^39
 ;;^UTILITY(U,$J,358.3,9319,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9319,1,3,0)
 ;;=3^Sarcoid Arthropathy
 ;;^UTILITY(U,$J,358.3,9319,1,4,0)
 ;;=4^D86.86
 ;;^UTILITY(U,$J,358.3,9319,2)
 ;;=^5002451
 ;;^UTILITY(U,$J,358.3,9320,0)
 ;;=D86.87^^39^411^43
 ;;^UTILITY(U,$J,358.3,9320,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9320,1,3,0)
 ;;=3^Sarcoid Myositis
 ;;^UTILITY(U,$J,358.3,9320,1,4,0)
 ;;=4^D86.87
 ;;^UTILITY(U,$J,358.3,9320,2)
 ;;=^5002452
 ;;^UTILITY(U,$J,358.3,9321,0)
 ;;=D86.3^^39^411^49
 ;;^UTILITY(U,$J,358.3,9321,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9321,1,3,0)
 ;;=3^Sarcoidosis of Skin
 ;;^UTILITY(U,$J,358.3,9321,1,4,0)
 ;;=4^D86.3
 ;;^UTILITY(U,$J,358.3,9321,2)
 ;;=^5002445
 ;;^UTILITY(U,$J,358.3,9322,0)
 ;;=D86.81^^39^411^41
 ;;^UTILITY(U,$J,358.3,9322,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9322,1,3,0)
 ;;=3^Sarcoid Meningitis
 ;;^UTILITY(U,$J,358.3,9322,1,4,0)
 ;;=4^D86.81
 ;;^UTILITY(U,$J,358.3,9322,2)
 ;;=^5002446
 ;;^UTILITY(U,$J,358.3,9323,0)
 ;;=D86.82^^39^411^50
 ;;^UTILITY(U,$J,358.3,9323,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9323,1,3,0)
 ;;=3^Sarcoidosis,Multiple Cranial Nerve Palsies
 ;;^UTILITY(U,$J,358.3,9323,1,4,0)
 ;;=4^D86.82
 ;;^UTILITY(U,$J,358.3,9323,2)
 ;;=^5002447
 ;;^UTILITY(U,$J,358.3,9324,0)
 ;;=D86.84^^39^411^44
 ;;^UTILITY(U,$J,358.3,9324,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9324,1,3,0)
 ;;=3^Sarcoid Pyelonephritis
 ;;^UTILITY(U,$J,358.3,9324,1,4,0)
 ;;=4^D86.84
 ;;^UTILITY(U,$J,358.3,9324,2)
 ;;=^5002449
 ;;^UTILITY(U,$J,358.3,9325,0)
 ;;=D86.85^^39^411^42
 ;;^UTILITY(U,$J,358.3,9325,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9325,1,3,0)
 ;;=3^Sarcoid Myocarditis
 ;;^UTILITY(U,$J,358.3,9325,1,4,0)
 ;;=4^D86.85
 ;;^UTILITY(U,$J,358.3,9325,2)
 ;;=^5002450
 ;;^UTILITY(U,$J,358.3,9326,0)
 ;;=D86.83^^39^411^40
 ;;^UTILITY(U,$J,358.3,9326,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9326,1,3,0)
 ;;=3^Sarcoid Iridocyclitis
 ;;^UTILITY(U,$J,358.3,9326,1,4,0)
 ;;=4^D86.83
 ;;^UTILITY(U,$J,358.3,9326,2)
 ;;=^5002448
 ;;^UTILITY(U,$J,358.3,9327,0)
 ;;=D84.1^^39^411^16
 ;;^UTILITY(U,$J,358.3,9327,1,0)
 ;;=^358.31IA^4^2
